US President Donald Trump has recovered from the Corona virus, after receiving a mixture of Regeneron, which Colorado Medical University says is laboratory designed and based on antibodies. The drug that Regeneron contributes to manufacturing, and which has entered the third and final stage of clinical trials, is considered an experimental mixture of antibodies, while the US Federal Food and Drug Administration has not yet approved the drug for most hospitalized Coronavirus patients, but Trump received the drug according to what It is known as “compassionate use.”
And Dr. Thomas Campbell, MD, Colorado Medical University, conducted clinical trials to see the potential of Regeneron combination. The drug has a scientific name, “Regen-Cove 2”, which is a familiar treatment for Dr. Thomas, who is overseeing clinical trials in Colorado with the support of Regeneron to understand and monitor the drug’s safety and effectiveness. According to Dr. Thomas, whose studies are currently focused on testing the performance of treatment on patients whose condition requires hospitalization and hospitalization for more than a day, the effectiveness of the drug will remain an open question.
The “Region-Cove 2” treatment contains two types of antibodies called “monoclonal”. These bodies are defined, according to the Mayo Clinic website, as laboratory-manufactured molecules to act as alternative antibodies that can restore, enhance or mimic the immune system’s attacks on aggressive cells that attack the body. They are designed to bind with antigens that are generally found more on the surface of cells. Aggressive ones against healthy cells.
Follow the world news from the statement via Google News
These were the details of the news “Regeneron” The secret of Trump’s recovery from Corona infection – one... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.